Multicenter Observational Study of Ceftaroline Fosamil for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections

Novel therapies for methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection (BSI) are needed in the setting of reduced antibiotic susceptibilities and therapeutic failure. Ceftaroline is a cephalosporin antibiotic with MRSA activity. Although not FDA approved for MRSA BSI, ceftaroli...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Antimicrob Agents Chemother
Auteurs principaux: Zasowski, Evan J., Trinh, Trang D., Claeys, Kimberly C., Casapao, Anthony M., Sabagha, Noor, Lagnf, Abdalhamid M., Klinker, Kenneth P., Davis, Susan L., Rybak, Michael J.
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2017
Sujets:
Clinical Therapeutics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5278749/
https://ncbi.nlm.nih.gov/pubmed/27895012
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02015-16
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires